期刊文献+
共找到99篇文章
< 1 2 5 >
每页显示 20 50 100
Simultaneous pancreas-kidney transplantation for end-stage renal failure in type 1 diabetes mellitus: Current perspectives
1
作者 Lakshmi Nagendra Cornelius James Fernandez Joseph M Pappachan 《World Journal of Transplantation》 2023年第5期208-220,共13页
Type 1 diabetes mellitus(T1DM)is one of the important causes of chronic kidney disease(CKD)and end-stage renal failure(ESRF).Even with the best available treatment options,management of T1DM poses significant challeng... Type 1 diabetes mellitus(T1DM)is one of the important causes of chronic kidney disease(CKD)and end-stage renal failure(ESRF).Even with the best available treatment options,management of T1DM poses significant challenges for clinicians across the world,especially when associated with CKD and ESRF.Substantial increases in morbidity and mortality along with marked rise in treatment costs and marked reduction of quality of life are the usual consequences of onset of CKD and progression to ESRF in patients with T1DM.Simultaneous pancreas-kidney transplant(SPK)is an attractive and promising treatment option for patients with advanced CKD/ESRF and T1DM for potential cure of these diseases and possibly several complications.However,limited availability of the organs for transplantation,the need for long-term immunosuppression to prevent rejection,peri-and post-operative complications of SPK,lack of resources and the expertise for the procedure in many centers,and the cost implications related to the surgery and postoperative care of these patients are major issues faced by clinicians across the globe.This clinical update review compiles the latest evidence and current recommendations of SPK for patients with T1DM and advanced CKD/ESRF to enable clinicians to care for these diseases. 展开更多
关键词 Type 1 diabetes mellitus Chronic kidney disease End-stage renal failure simultaneous pancreas-kidney transplantation Perioperative complications IMMUNOSUPPRESSION
下载PDF
PREVENTION AND TREATMENT OF REJECTION AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION 被引量:3
2
作者 Lei Yang Yong-feng Liu Shu-rong Liu Gang Wu Jia-lin Zhang Yi-man Meng Shao-wei Shong Gui-chen Li 《Chinese Medical Sciences Journal》 CAS CSCD 2005年第3期210-213,共4页
Objective To explore methods of preventing and reversing rejection after simultaneous pancreas-kidney (SPK) transplantation. Methods Seventeen patients underwent SPK transplantation from September 1999 to September... Objective To explore methods of preventing and reversing rejection after simultaneous pancreas-kidney (SPK) transplantation. Methods Seventeen patients underwent SPK transplantation from September 1999 to September 2003 were reviewed retrospectively. Immunosuppression was achieved by a triple drug regimen consisting of cyclosporine, mycophenolate mofleil (MMF), and steroids. Three patients were treated with anti-CD3 monoclone antibody (OKT3, 5 mg·d^-1) for induction therapy for a mean period of 5-7 days. One patients received IL-2 receptor antibodies (daclizumab) in a dose of I mg·kg^-1 on the day of transplant and the 5th day posttransplant. One patient was treated with both OKT3 and daclizumab for induction. Results No primary non-functionality of either kidney or pancreas occurred in this series of transplantations. Function of all the kidney grafts recovered within 2 to 4 days after transplantation. The level of serum creatinine was 94 ± 11 μmol/L on the 7th day posttransplant. One patient experienced the accelerated rejection, resulting in the resection of the pancreas and kidney grafts because of the failure of conservative therapy. The incidence of the first rejection episodes at 3 months was 47.1% (8/17). Only the kidney was involved in 35.3% (6/17); and both the pancreas and kidney were involved in 11.8% (2/17). All these patients received a high-dose pulse of methylprednisone (0.5 g·d^-1) for 3 days. OKT3 (0.5 mg·d^-1) was administered for 7-10 days in two patients with both renal and pancreas rejection. All the grafts were successfully rescued. Conclusion Rejection, particularly acute rejection, is the major cause influencing graft function in SPK transplantation. Monitoring renal function and pancreas exocrine secretion, and reasonable application of immunosuppressants play important roles in the diagnosis and treatment of rejection. 展开更多
关键词 simultaneous pancreas-kidney transplantation REJECTION
下载PDF
Establishment of simultaneous pancreas and kidney transplantation (SPK) model with cuff technique and portal venous drainage in rats
3
作者 Shuguang Han Zekuan Xu Xuan Zhang Yi Miao 《Journal of Nanjing Medical University》 2007年第1期8-10,共3页
To establish a simultaneous pancreas and kidney transplantation (SPK) model in the rat. Methods: SD rats served as donors and recipients. The donor portal vein and the recipient superior mesenteric vein were anasto... To establish a simultaneous pancreas and kidney transplantation (SPK) model in the rat. Methods: SD rats served as donors and recipients. The donor portal vein and the recipient superior mesenteric vein were anastomosed and the donor renal veins and recipient renal veins were anastomosed by cuff method. Arterial reconstruction was carried out by end to side anastomosis of the donor abdominal aorta to the recipient abdominal aorta. Enteric drainage was performed by side to side anastomosis between donors' duodenum and recipients' jejunum. The donor ureter -bladder valve was anastomosed to the bladder of recipients. Results: Out of 30 cases of SPK transplantation, 24 had normal serum glucose and serum creatinine after operation. The successful rate was 80 %. Conclusion: This model of SPK in rats is stable and reliable, which could be applied for further scientific research. 展开更多
关键词 simultaneous pancreas and kidney transplantation RAT MODEL
下载PDF
Simultaneous liver-kidney transplantation:Single-center study
4
作者 魏来 《外科研究与新技术》 2011年第4期273-273,共1页
Objective To analyze the curative effect of simultaneous liver and kidney transplantation ( SLKT) for patients with end - stage liver and kidney diseases and liver cirrhosis patients with hepatorenal syndrome. Methods... Objective To analyze the curative effect of simultaneous liver and kidney transplantation ( SLKT) for patients with end - stage liver and kidney diseases and liver cirrhosis patients with hepatorenal syndrome. Methods All SLKTs ( n = 21) performed at our center from January 1999 to December 2010 were reviewed and 展开更多
关键词 RATE simultaneous liver-kidney transplantation
下载PDF
Outcomes of liver transplantation in patients with hepatorenal syndrome 被引量:8
5
作者 Rohan M Modi Nishi Patel +1 位作者 Sherif N Metwally Khalid Mumtaz 《World Journal of Hepatology》 CAS 2016年第24期999-1011,共13页
Hepatorenal syndrome(HRS) plays an important role in patients with liver cirrhosis on the wait list for liver transplantation(LT). The 1 and 5-year probability of developing HRS in cirrhotic with ascites is 20% and 40... Hepatorenal syndrome(HRS) plays an important role in patients with liver cirrhosis on the wait list for liver transplantation(LT). The 1 and 5-year probability of developing HRS in cirrhotic with ascites is 20% and 40%, respectively. In this article, we reviewed current concepts in HRS pathophysiology, guidelines for HRS diagnosis, effective treatment options presently available, and controversies surrounding liver alone vs simultaneous liver kidney transplant(SLKT) in transplant candidates. Many treatment options including albumin, vasoconstrictors, renal replacement therapy, and eventual LT have remained a mainstay in the treatment of HRS. Unfortunately, even after aggressive measures such as terlipressin use, the rate of recovery is less than 50% of patients. Moreover, current SLKT guidelines include:(1) estimation of glomerular filtration rate of 30 m L/min or less for 4-8 wk;(2) proteinuria > 2 g/d; or(3) biopsy proven interstitial fibrosis or glomerulosclerosis. Even with these updated criteria there is a lack of consistency regarding longterm benefits for SLKT vs LT alone. Finally, in regards to kidney dysfunction in the post-transplant setting, an estimation of glomerular filtration rate < 60 mL /min per 1.73 m2 may be associated with an increased risk of patients having long-term end stage renal disease. HRS is common in patients with cirrhosis and those on liver transplant waitlist. Prompt identification and therapy initiation in transplant candidates with HRS may improve post-transplantation outcomes. Future studies identifying optimal vasoconstrictor regimens, alternative therapies, and factors predictive of response to therapy are needed. The appropriate use of SLKT in patients with HRS remains controversial and requires further evidence by the transplant community. 展开更多
关键词 LIVER transplantation simultaneous LIVER KIDNEY transplantation VASOPRESSORS DIALYSIS Posttransplant OUTCOMES Hepatorenal syndrome
下载PDF
Pancreas transplantation in type Ⅱ diabetes mellitus 被引量:2
6
作者 Phillip Weems Matthew Cooper 《World Journal of Transplantation》 2014年第4期216-221,共6页
Although the diagnosis of type 2 diabetes mellitus was once considered a contraindication to simultaneous pancreas-kidney transplantation, a growing body of evidence has revealed that similar graft and patient surviva... Although the diagnosis of type 2 diabetes mellitus was once considered a contraindication to simultaneous pancreas-kidney transplantation, a growing body of evidence has revealed that similar graft and patient survival can be achieved when compared to type 1 diabetes mellitus recipients. A cautious strategy regarding candidate selection may limit appropriate candidates from additional benefits in terms of quality of life and potential amelioration of secondary side effects of the disease process. Although our current understanding of the disease has changed, uniform listing characteristics to better define and study this population have limited available data and must be established. 展开更多
关键词 PANCREAS transplantation TYPE 2 diabetes MELLITUS simultaneous pancreas-kidney transplantation
下载PDF
Exocrine drainage in vascularized pancreas transplantation in the new millennium 被引量:2
7
作者 Hany El-Hennawy Robert J Stratta Fowler Smith 《World Journal of Transplantation》 2016年第2期255-271,共17页
The history of vascularized pancreas transplantation largely parallels developments in immunosuppression and technical refinements in transplant surgery. From the late-1980 s to 1995, most pancreas transplants were wh... The history of vascularized pancreas transplantation largely parallels developments in immunosuppression and technical refinements in transplant surgery. From the late-1980 s to 1995, most pancreas transplants were whole organ pancreatic grafts with insulin delivery to the iliac vein and diversion of the pancreatic ductal secretions to the urinary bladder(systemic-bladder technique). The advent of bladder drainage revolutionized the safety and improved the success of pancreas transplantation. However, starting in 1995, a seismic change occurred from bladder to bowel exocrine drainage coincident with improvements in immunosuppression, preservation techniques, diagnostic monitoring, general medical care, and the success and frequency of enteric conversion. In the new millennium, pancreas transplants are performed predominantly as pancreatico-duodenal grafts with enteric diversion of the pancreatic ductal secretions coupled with iliac vein provision of insulin(systemic-enteric technique) although the systemic-bladder technique endures as a preferred alternative in selected cases. In the early 1990 s, a novel technique of venous drainage into the superior mesenteric vein combined with bowel exocrine diversion(portal-enteric technique) was designed and subsequently refined over the next ≥ 20 years to recreate the natural physiology of the pancreas with firstpass hepatic processing of insulin. Enteric drainage usually refers to jejunal or ileal diversion of the exocrine secretions either with a primary enteric anastomosis or with an additional Roux limb. The portal-enteric technique has spawned a number of newer and revisited techniques of enteric exocrine drainage including duodenal or gastric diversion. Reports in the literature suggest no differences in pancreas transplant outcomes irrespective of type of either venous or exocrine diversion. The purpose of this review is to examine theliterature on exocrine drainage in the new millennium(the purported "enteric drainage" era) with special attention to technical variations and nuances in vascularized pancreas transplantation that have been proposed and studied in this time period. 展开更多
关键词 PANCREAS transplantation Portal-enteric drainage simultaneous pancreas-kidney transplant Systemic-bladder drainage ENTERIC conversion SOLITARY PANCREAS transplant Systemic-enteric drainage
下载PDF
Pancreas transplantation: The Wake Forest experience in the new millennium
8
作者 Jeffrey Rogers Alan C Farney +7 位作者 Giuseppe Orlando Samy S Iskandar William Doares Michael D Gautreaux Scott Kaczmorski Amber Reeves-Daniel Amudha Palanisamy Robert J Stratta 《World Journal of Diabetes》 SCIE CAS 2014年第6期951-961,共11页
AIM: To investigate the Wake Forest experience with pancreas transplantation in the new millennium with attention to surgical techniques and immunosuppression. METHODS: A monocentric, retrospective review of outcomes ... AIM: To investigate the Wake Forest experience with pancreas transplantation in the new millennium with attention to surgical techniques and immunosuppression. METHODS: A monocentric, retrospective review of outcomes in simultaneous kidney-pancreas transplant(SKPT) and solitary pancreas transplant(SPT) recipients was performed. All patients underwent pancreas transplantation as intent-to-treat with portal venous and enteric exocrine drainage and received depleting antibody induction; maintenance therapy included tapered steroids or early steroid elimination with my-cophenolate and tacrolimus. Recipient selection was based on clinical judgment whether or not the patient exhibited measureable levels of C-peptide. RESULTS: Over an 11.25 year period, 202 pancreas transplants were performed in 192 patients including 162 SKPTs and 40 SPTs. A total of 186(92%) were primary and 16(8%) pancreas retransplants; portalenteric drainage was performed in 179 cases. A total of 39 pancreas transplants were performed in African American(AA) patients; of the 162 SKPTs, 30 were performed in patients with pretransplant C-peptide levels 】 2.0 ng/m L. In addition, from 2005-2008, 46 SKPT patients were enrolled in a prospective study of single dose alemtuzumab vs 3-5 doses of rabbit antithymocyte globulin induction therapy. With a mean follow-up of 5.7 in SKPT vs 7.7 years in SPT recipients, overall patient(86% SKPT vs 87% SPT) and kidney(74% SKPT vs 80% SPT) graft survival rates as well as insulin-free rates(both 65%) were similar(P = NS). Although mortality rates were nearly identical in SKPT compared to SPT recipients, patterns and timing of death were different as no early mortality occurred in SPT recipients whereas the rates of mortality following SKPT were 4%, 9% and 12%, at 1-, 3- and 5-years follow-up, respectively(P 【 0.05). The primary cause of graft loss in SKPT recipients was death with a functioning graft whereas the major cause of graft loss following SPT was acute and chronic rejection. The overall incidence of acute rejection was 29% in SKPT and 27.5% in SPT recipients(P = NS). Lower rates of acute rejection and major infection were evidenced in SKPT patients receiving alemtuzumab induction therapy. Comparable kidney and pancreas graft survival rates were observed in AA and non-AA recipients despite a higher prevalence of a “type 2 diabetes” phenotype in AA. Results comparable to those achieved in insulinopenic diabetics were found in the transplantation of type 2 diabetics with detectable C-peptide levels.CONCLUSION: In the new millennium, acceptablemedium-term outcomes can be achieved in SKPT and SPTs as nearly 2/3rds of patients are insulin independent following pancreas transplantation. 展开更多
关键词 ALEMTUZUMAB Mycophenolate mofetil Pancreas transplantation Portal-enteric Rabbit anti-thymocyte globulin simultaneous kidney-pancreas transplantation Solitary pancreas transplantation Steroid elimination Surveillance biopsy TACROLIMUS
下载PDF
Mortality assessment for pancreas transplants in the United States over the decade 2008-2018
9
作者 Tambi Jarmi Emily Brennan +1 位作者 Jacob Clendenon Aaron C Spaulding 《World Journal of Transplantation》 2023年第4期147-156,共10页
BACKGROUND Pancreas transplant is the only treatment that establishes normal glucose levels for patients diagnosed with diabetes.However,since 2005,no comprehensive analysis has compared survival outcomes of:(1)Simult... BACKGROUND Pancreas transplant is the only treatment that establishes normal glucose levels for patients diagnosed with diabetes.However,since 2005,no comprehensive analysis has compared survival outcomes of:(1)Simultaneous pancreas-kidney(SPK)transplant;(2)Pancreas after kidney(PAK)transplant;and(3)Pancreas transplant alone(PTA)to waitlist survival.AIM To explore the outcomes of pancreas transplants in the United States during the decade 2008-2018.METHODS Our study utilized the United Network for Organ Sharing Standard Transplant Analysis and Research file.Pre-and post-transplant recipient and waitlist characteristics and the most recent recipient transplant and mortality status were used.We included all patients with type I diabetes listed for pancreas or kidneypancreas transplant between May 31,2008 and May 31,2018.Patients were grouped into one of three transplant types:SPK,PAK,or PTA.RESULTS The adjusted Cox proportional hazards models comparing survival between transplanted and non-transplanted patients in each transplant type group showed that patients who underwent an SPK transplant exhibited a significantly reduced hazard of mortality[hazard ratio(HR)=0.21,95%confidence intervals(CI):0.19-0.25]compared to those not transplanted.Neither PAK transplanted patients(HR=1.68,95%CI:0.99-2.87)nor PTA patients(HR=1.01,95%CI:0.53-1.95)experienced significantly different hazards of mortality compared to patients who did not receive a transplant.CONCLUSION When assessing each of the three transplant types,only SPK transplant offered a survival advantage compared to patients on the waiting list.PKA and PTA transplanted patients demonstrated no significant differences compared to patients who did not receive a transplant. 展开更多
关键词 Pancreas transplant simultaneous pancreas-kidney transplant Pancreas after kidney transplant Survival Diabetes mellitus INSULIN
下载PDF
超声造影在胰腺移植中的研究进展
10
作者 史晓峰 莫春柏 《实用医学杂志》 CAS 北大核心 2024年第8期1171-1174,1180,共5页
胰腺移植治疗糖尿病,尤其是胰肾联合移植应用于治疗糖尿病合并终末期肾病的临床效果日益改善,使得越来越多的移植中心开展胰腺移植手术。但复杂的手术和各种并发症,降低了患者和移植物的生存率。特别是术后早期较高的血管并发症发生率... 胰腺移植治疗糖尿病,尤其是胰肾联合移植应用于治疗糖尿病合并终末期肾病的临床效果日益改善,使得越来越多的移植中心开展胰腺移植手术。但复杂的手术和各种并发症,降低了患者和移植物的生存率。特别是术后早期较高的血管并发症发生率。而超声造影在胰腺移植术后的应用越来越显示出了优越性。本文主要就超声造影在胰腺移植术后血管评估、供体胰腺评估、血栓形成、预测胰岛素分泌能力、排斥反应及并发症方面的应用加以综述,以期为胰腺移植的临床应用和深入研究提供参考。 展开更多
关键词 胰腺移植 胰肾联合移植 超声造影
下载PDF
2型糖尿病合并终末期肾病患者同期胰肾联合移植术后危险因素:UNOS数据库50230例分析
11
作者 夏新泽 赖文辉 +6 位作者 黄帅 安哲昆 郝晓伟 吕凯凯 罗振君 袁清 蔡明 《解放军医学杂志》 CAS CSCD 北大核心 2024年第4期371-379,共9页
目的比较2型糖尿病(T2DM)合并终末期肾病(ESRD)患者行同期胰肾联合移植(SPKT)或尸体肾移植(DDKT)后的移植肾及患者生存情况,并分析SPKT术后影响患者存活的危险因素。方法获取美国器官资源共享网络(UNOS)数据库中2003年1月27日-2021年1月... 目的比较2型糖尿病(T2DM)合并终末期肾病(ESRD)患者行同期胰肾联合移植(SPKT)或尸体肾移植(DDKT)后的移植肾及患者生存情况,并分析SPKT术后影响患者存活的危险因素。方法获取美国器官资源共享网络(UNOS)数据库中2003年1月27日-2021年1月1日接受肾脏移植患者的临床及预后资料。根据纳入、排除标准最终纳入50230例,其中DDKT组48669例,SPKT组1561例。采用Kaplan-Meier法比较两组受者的移植肾及患者存活情况,并通过倾向性评分匹配(PSM)均衡组间混杂因素。采用Cox回归模型分析SPKT术后影响患者生存的独立危险因素。结果与DDKT组比较,SPKT组受者的中位年龄小(P<0.001)、男性占比高(P<0.001)、BMI低(P<0.001)、透析时间和移植等待时间短(P<0.001)、私人医保占比高(P<0.001)、既往移植占比低(P<0.001)、糖尿病确诊年龄低(P<0.001)、外周血管病史少(P=0.033);与DDKT组比较,SPKT组供者的中位年龄小(P<0.001)、男性占比高(P<0.001)、BMI低(P<0.001)、高血压病史和糖尿病史少见(P<0.001);在移植相关因素上,与DDKT组比较,SPKT组的供肾冷缺血时间短(P<0.001)、HLA错配程度高(P<0.001)、KDPI低(P<0.001)。与DDKT组比较,SPKT组出院时血肌酐水平低(P<0.001)、术后移植肾功能恢复延迟(DGF)发生率和AR发生率低(P<0.001),住院时间长(P<0.001)。原始和PSM后的Kaplan-Meier生存分析曲线均显示SPKT组的移植肾和患者存活率明显高于DDKT组(P<0.001)。Cox回归模型分析显示,受者年龄、受者种族、供者年龄和供肾冷缺血时间是影响SPKT术后患者存活的独立危险因素(P<0.05)。结论T2DM合并ESRD患者行SPKT较DDKT的远期移植肾和患者存活率高。受者年龄、受者种族、供者年龄和供肾冷缺血时间是影响SPKT术后患者存活的独立危险因素。 展开更多
关键词 肾移植 同期胰肾联合移植 倾向性评分匹配 生存分析 预后因素
下载PDF
Alcohol associated liver disease and bariatric surgery:Current perspectives and future directions
12
作者 Katherine M Cooper Alessandro Colletta +1 位作者 Nicholas Hebda Deepika Devuni 《World Journal of Gastrointestinal Surgery》 SCIE 2024年第3期650-657,共8页
Bariatric surgery is a routinely performed procedure and is associated with a reduction in all-cause mortality in patients with obesity.However,bariatric sur-gery has also been linked to increased alcohol use with up ... Bariatric surgery is a routinely performed procedure and is associated with a reduction in all-cause mortality in patients with obesity.However,bariatric sur-gery has also been linked to increased alcohol use with up to 30%of these patients developing alcohol use disorder(AUD).The mechanism of AUD after bariatric surgery is multifactorial and includes anatomic,metabolic,and neurohumoral changes associated with post-surgical anatomy.These patients are at increased risk of alcohol associated liver disease and,in some cases,require liver trans-plantation.In this article,we provide a scoping review of epidemiology,patho-physiology,and clinical outcomes of alcohol-related health conditions after bariatric surgery. 展开更多
关键词 Obesity medicine Alcohol use disorder Roux-en-Y gastric bypass Vertical sleeve gastrectomy Liver transplant simultaneous liver transplant and bariatric surgery
下载PDF
Simultaneous pancreas-kidney transplantation in a single center: 10-year retrospective analysis 被引量:2
13
作者 ZHENG Jian-ming SONG Wen-li TU Jin-peng FENG Gang MO Chun-bai SHEN Zhong-yang 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第5期683-686,共4页
Background Simultaneous pancreas-kidney transplantation (SPKT) is the best treatment option for diabetic patients with advanced chronic renal failure. The current study aimed to analyze the surgical indications, tre... Background Simultaneous pancreas-kidney transplantation (SPKT) is the best treatment option for diabetic patients with advanced chronic renal failure. The current study aimed to analyze the surgical indications, treatments and prognosis of SPKT.Methods We retrospectively analyzed 40 cases of SPKT performed between December 1999 and January 2010 in our center, including the survival rate, complications and the reasons of reoperation.Results Of all the 40 SPKT cases, the one-year survival rates of the recipients, kidney and pancreas transplant graft were 97.6%, 97.6% and 92.7%, while 97.6%, 91.1%, 92.7% at 3 years and 83.6%, 78.0%, 79.4% at 5 years, respectively. After SPKT, 10 patients need reoperation because of surgical complications (14 operations). The reoperation rate was 25%, including 2 patients (4 operations) with hematuria, 4 patients with abdominal hemorrhage, 2 patients (3 operations) with abdominal infection, 1 patient with pancreatic venous thrombosis, 1 patient with anastomotic leakage, and 1 patient with fistula.Conclusion Although SPKT provides a successful and effective treatment for diabetics with end-stage renal disease, how to reduce the complications of this treatment still need further effort. 展开更多
关键词 simultaneous pancreas-kidney transplantation diabetes mellitus end-stage renal disease
原文传递
胰肾联合移植受者病原菌分布及耐药特征分析 被引量:2
14
作者 陈荣鑫 方佳丽 +7 位作者 张磊 李光辉 刘路浩 张鹏 吴佳林 马俊杰 郭泽彬 陈正 《器官移植》 CAS CSCD 北大核心 2023年第2期280-287,共8页
目的探讨胰肾联合移植供、受者病原菌分布特点及耐药特征。方法回顾性分析231例胰肾联合移植供、受者的临床资料。供、受者标本采用VITEK-2分析仪进行病原菌鉴定,K-B法进行药敏试验。分析供受者标本病原菌来源分布与构成比、多重耐药菌... 目的探讨胰肾联合移植供、受者病原菌分布特点及耐药特征。方法回顾性分析231例胰肾联合移植供、受者的临床资料。供、受者标本采用VITEK-2分析仪进行病原菌鉴定,K-B法进行药敏试验。分析供受者标本病原菌来源分布与构成比、多重耐药菌分布特征、受者感染发生情况及病原菌耐药特征。结果供者1294份标本共培养出395株病原菌,检出率为30.53%。革兰阴性菌以肺炎克雷伯菌为主,革兰阳性菌以金黄色葡萄球菌为主,真菌主要为白假丝酵母菌。受者10507份标本共培养出2690株病原菌,检出率为25.60%。革兰阴性菌以嗜麦芽假单胞菌为主,革兰阳性菌以屎肠球菌为主,真菌主要为白假丝酵母菌。供者395株病原菌中,耐甲氧西林金黄色葡萄球菌(MRSA)15株、产超广谱β内酰胺酶(ESBL)阳性耐药菌16株、耐碳青霉烯类铜绿假单胞菌(CR-PA)8株、耐碳青霉烯类鲍曼不动杆菌(CR-AB)21株、耐碳青霉烯类肠杆菌科细菌(CRE)2株、多重耐药/泛耐药铜绿假单胞菌(MDR/PDR-PA)1株;受者2690株病原菌中,ESBL阳性耐药菌73株、CR-PA 44株、CR-AB 31株、MDR/PDR-PA 3株。受者发生供者来源性感染1例,术后1年内发生肺炎69例、泌尿系统感染52例、腹腔感染35例、血行感染2例。革兰阴性菌对部分抗生素耐药;革兰阳性菌对万古霉素敏感;真菌对两性霉素B敏感。结论革兰阴性菌是SPK受者主要感染病原菌,对部分抗生素耐药,未获得培养结果前可经验性应用抗生素,后根据结果合理选用敏感抗生素以提高SPK受者生存率。 展开更多
关键词 胰肾联合移植 病原菌 多重耐药菌 革兰阴性菌 革兰阳性菌 真菌 供者来源性感染 抗生素
下载PDF
两种胰液引流术式的胰肾联合移植临床效果比较 被引量:1
15
作者 蓝柳根 李美思 +7 位作者 高照 董建辉 秦科 黄莹 曹嵩 李海滨 雷志影 孙煦勇 《实用器官移植电子杂志》 2023年第6期514-518,共5页
目的 分析53例糖尿病并终末期肾病患者行同期胰肾联合移植不同胰液引流术式的临床效果对比。方法 2010年5月至2019年12月广西医科大学第二附属医院移植医学中心完成了53例同期胰肾联合移植手术,其中胰液膀胱引流(bladder drainage,BD)术... 目的 分析53例糖尿病并终末期肾病患者行同期胰肾联合移植不同胰液引流术式的临床效果对比。方法 2010年5月至2019年12月广西医科大学第二附属医院移植医学中心完成了53例同期胰肾联合移植手术,其中胰液膀胱引流(bladder drainage,BD)术式22例,胰液空肠引流(enteric drainage,ED)术式组31例。对比两组不同胰液引流术式受者的移植肾功能延迟恢复发生率、术后移植胰腺功能延迟恢复发生率、胰腺冷缺血时间、移植胰腺1年生存率、手术时间、再手术率、术中总输血量、术后1个月血糖变化、其他并发症等。结果 53例胰肾联合移植手术成功,随访4~90个月,在22例BD术式中,有1例患者发生坏死性胰腺炎,切除胰腺。3例患者出现移植肾功能延迟恢复,有1例患者移植肾功能延迟恢复,恢复有尿后发生出血性膀胱炎,后并发肺部感染而死亡。移植后(14.2±5.1)d空腹血糖降至正常,(9.5±4.2)d停止使用胰岛素,(10.4±6.5)d肾功能恢复正常。平均住院时间为(21.4±7.3)d,术后出现并发症有移植胰腺静脉血栓2例,泌尿系感染1例,移植胰淋巴漏1例,切口感染1例,他克莫司中毒1例、移植肾急性排斥反应1例。21例患者长期存活。在31例ED术式组中,术后(12.2±5.1)d空腹血糖降至正常,(7.3±3.2)d停止使用胰岛素,(11.2±5.7)d肾功能恢复正常。平均住院时间为(18.6±6.6)d,2例患者术后出现移植胰腺静脉血栓形成,切除胰腺。2例患者出现坏死性胰腺炎,切除胰腺。移植肾急性排斥反应(经活检证实)2例,移植胰切口感染2例,他克莫司中毒1例。31例患者长期长期存活。结论 胰肾联合移植胰液空肠引流术式组受者并没有增加手术风险,且受者及移植物存活率未受影响,患者生活质量高于膀胱引流组,胰肾联合移植手术胰液空肠引流术式的临床效果和安全性较好,临床上值得推广。 展开更多
关键词 同期胰肾联合移植 胰液引流方式 临床疗效
下载PDF
胰腺移植术后早期移植胰腺血栓形成的危险因素分析
16
作者 李美思 董建辉 +6 位作者 乔鹏飞 吴基华 秦科 蓝柳根 雷志影 王洪良 孙煦勇 《实用器官移植电子杂志》 2023年第6期545-550,共6页
目的评估胰腺移植术后早期血栓形成的危险因素。方法选取2015年1月至2019年8月中国人民解放军联勤保障部队第九二三医院46例脑死亡器官捐献(donation after brain death,DBD)供体同期胰肾联合移植(simultaneous pancreas-kidney transpl... 目的评估胰腺移植术后早期血栓形成的危险因素。方法选取2015年1月至2019年8月中国人民解放军联勤保障部队第九二三医院46例脑死亡器官捐献(donation after brain death,DBD)供体同期胰肾联合移植(simultaneous pancreas-kidney transplantation,SPK)受者及2019年11月至2023年7月在广西医科大学第二附属医院30例DBD供体SPK受者,根据是否发生血栓分为血栓组及无血栓组。对两组受者进行回顾性研究,评估供受体的特征与胰腺移植术后早期血栓形成的危险因素。结果供受体年龄增加与胰腺血栓形成关系不大(P>0.05),受体体重指数(body mass index,BMI)与移植胰腺血栓形成关系密切(P=0.01),胰腺外分泌液引流选择方式对移植胰腺血栓关系不大(P=0.49),采用动脉或静脉来延长供胰静脉与胰腺移植术后血栓形成有关(P=0.02),接受肝素后序贯用阿司匹林比单用阿司匹林的受者血栓形成的发生率较低(P=0.04)。供者淀粉酶的变化是移植胰腺血栓形成的危险因素(P=0.04),受者术后第7天D二聚体(D-dimer,D-D)的变化提示移植胰腺血栓的形成。结论受者BMI、动脉或静脉延长供胰静脉、是否使用肝素、供体淀粉酶变化是胰腺移植术后早期血栓形成的危险因素。 展开更多
关键词 胰腺移植 胰肾联合移植 血栓
下载PDF
单中心胰肾联合移植的远期疗效观察
17
作者 王洪良 黄晨 +7 位作者 刘飞 乔鹏飞 刘越 蓝柳根 吴基华 董建辉 李美思 孙煦勇 《实用器官移植电子杂志》 2023年第6期509-513,共5页
目的回顾性分析单中心58例胰肾联合移植的远期疗效及相关影响因素。方法回顾性分析中国人民解放军联勤保障部队第九二三医院器官移植科2010年5月至2019年12月完成的58例胰肾联合移植手术受者和移植器官的存活率,并分析移植器官功能丢失... 目的回顾性分析单中心58例胰肾联合移植的远期疗效及相关影响因素。方法回顾性分析中国人民解放军联勤保障部队第九二三医院器官移植科2010年5月至2019年12月完成的58例胰肾联合移植手术受者和移植器官的存活率,并分析移植器官功能丢失和受者死亡原因。结果1、3、5、8年受者生存率分别为98.28%、98.28%、92.24%、89.99%,移植胰腺存活率分别为86.21%、84.48%、78.40%、76.16%,移植肾存活率分别为98.28%、98.28%、82.83%、80.60%,胰液膀胱引流(bladder drainage,BD)术式1、3、5、8年生存率为96.15%、96.15%、86.73%、86.73%,胰液空肠引流(enteric drainage,ED)术式1、3、5、8年生存率为100%、100%、96.67%、93.33%(P=0.187)。结论胰肾联合移植对于终末期糖尿病肾病的远期疗效较好,ED术式可能会有更好的长期预后,外科并发症是影响胰肾联合移植远期疗效的主要因素,器官排斥反应、感染和受者带功死亡也是移植器官功能丢失的重要因素。 展开更多
关键词 糖尿病 终末期肾病 肾移植 胰腺移植 胰肾联合移植
下载PDF
护理干预对胰肾联合移植患者血糖控制的影响研究
18
作者 孟晓云 高利娜 +2 位作者 李野 刘志佳 李响 《实用器官移植电子杂志》 2023年第6期519-522,共4页
目的 门诊护理干预对接受胰肾联合移植患者血糖水平的影响。方法 将中国人民解放军总医院第八医学中心泌尿外科门诊随访的28例胰肾联合移植患者作为研究对象,将其分为观察组和对照组,各14例,其中对照组在门诊随访时进行护理和健康宣教... 目的 门诊护理干预对接受胰肾联合移植患者血糖水平的影响。方法 将中国人民解放军总医院第八医学中心泌尿外科门诊随访的28例胰肾联合移植患者作为研究对象,将其分为观察组和对照组,各14例,其中对照组在门诊随访时进行护理和健康宣教等常规工作,观察组实施本研究特定的护理干预方法,6个月后评价两组患者饮食、运动、生活习惯依从性,疾病知识掌握程度以及血糖控制水平的指标结果,比较两组患者对护理服务的满意度。结果 观察组患者饮食、运动、生活习惯依从性和掌握疾病知识程度均优于对照组,血糖值低于对照组,且护理服务满意度优于对照组,差异均具有统计学意义(均P <0.05)。结论 门诊护理干预可以有效改善胰肾联合移植患者血糖水平,增强患者自护能力和遵医行为,提升护理服务满意度,值得临床推广应用。 展开更多
关键词 胰肾联合移植 糖尿病 血糖 护理干预 随访
下载PDF
舒更葡糖钠与新斯的明拮抗胰肾联合移植术后残余肌松效果的比较 被引量:9
19
作者 周洪彬 黄焕森 +2 位作者 许阳英 刘浩 吴钿生 《实用医学杂志》 CAS 北大核心 2022年第3期366-369,共4页
目的比较舒更葡糖钠与新斯的明拮抗胰肾联合移植术后残余肌松的效果。方法收集2017年1月至2021年5月我院胰肾联合移植术患者152例,根据肌松拮抗剂使用情况分为:舒更葡糖钠组(S组)82例和新斯的明组(N组)70例。比较两组患者肌松拮抗剂效... 目的比较舒更葡糖钠与新斯的明拮抗胰肾联合移植术后残余肌松的效果。方法收集2017年1月至2021年5月我院胰肾联合移植术患者152例,根据肌松拮抗剂使用情况分为:舒更葡糖钠组(S组)82例和新斯的明组(N组)70例。比较两组患者肌松拮抗剂效能、术前及术后1、3、7、14 d的血清肌酐清除率、血淀粉酶值及空腹血糖值、两组术后并发症情况,组间比较计量资料采用两样本t检验或非参数检验,计数资料采用χ^(2)检验。结果与N组比较,S组肌松拮抗剂起效[3(2,7)min vs.15(10,32)min]、自主呼吸恢复[4(3,7)min vs.25(13,45)min]、气管拔管[17(10,25)min vs.47(30,86)min]和PACU停留时间[30(15,46)min vs.61(21,95)min]明显缩短(P<0.05),术后低氧血症[2(2.4%)vs.9(12.9%)]及肺部感染发生率[4(4.9%)vs.12(17.1%)]明显降低(P<0.05);两组各时点肌酐清除率、血淀粉酶、空腹血糖比较差异无统计学意义(P>0.05);两组其余并发症发生率比较差异无统计学意义(P>0.05)。结论与新斯的明相比,舒更葡糖钠有利于加快胰肾联合移植患者术后肌松恢复,降低术后早期肺部并发症发生率。 展开更多
关键词 舒更葡糖钠 新斯的明 胰肾联合移植 呼吸功能恢复 肺部并发症
下载PDF
D-二聚体在胰肾联合移植术后移植胰血栓形成的预测价值 被引量:7
20
作者 林岚 刘路浩 +1 位作者 张磊 熊石龙 《实用医学杂志》 CAS 北大核心 2022年第16期2071-2075,共5页
目的探讨D-二聚体在胰肾联合移植术后移植胰血栓形成的预测价值。方法选取2020年9月至2021年8月我院器官移植中心行胰肾联合移植术患者共54例,比较有移植胰血栓和无移植胰血栓患者术前1 d与术后1、3、7 d的D-二聚体水平变化情况;比较移... 目的探讨D-二聚体在胰肾联合移植术后移植胰血栓形成的预测价值。方法选取2020年9月至2021年8月我院器官移植中心行胰肾联合移植术患者共54例,比较有移植胰血栓和无移植胰血栓患者术前1 d与术后1、3、7 d的D-二聚体水平变化情况;比较移植胰有血栓时和无血栓时的D-二聚体水平;绘制ROC曲线分析移植胰血栓形成时D-二聚体水平对胰肾联合移植术后移植胰血栓的诊断效能。结果胰肾联合移植术后患者中,有移植胰血栓组和无移植胰血栓组的术前1 d的D-二聚体水平组间比较差异无统计学意义(P>0.05),术前1 d分别与术后1、3、7 d的D-二聚体水平组内比较差异均有统计学意义(P<0.05),术前1 d、术后1、3、7 d的D-二聚体水平组间比较差异均无统计学意义(P>0.05)。移植胰血栓形成时的D-二聚体水平与无血栓形成的术后D-二聚体水平比较差异有统计学意义(P<0.05)。根据ROC曲线,D-二聚体预测移植胰动静脉血栓的最佳临界值为3.305 mg/L,AUC为0.828,灵敏度为88.9%,特异度为77.8%,约登指数为66.7%。结论胰肾联合移植术后D-二聚体水平较术前显著升高,发生移植胰血栓时血浆D-二聚体水平升高幅度更大,可将D-二聚体3.305 mg/L作为筛查胰肾联合移植术后移植胰血栓的“风险值”。 展开更多
关键词 D-二聚体 胰肾联合移植 移植胰 血栓形成
下载PDF
上一页 1 2 5 下一页 到第
使用帮助 返回顶部